Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum Disorders

The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · see citing works

J Neuropsychiatry Clin Neurosci

Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818 · see citing works

The Yale-Brown Obsessive Compulsive Scale: II. Validity

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799 · see citing works

The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency

Kim, S. W., Dysken, M. W., Pheley, A. M., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,361 · see citing works

Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder

Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048 · see citing works

Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder

Mataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716 · see citing works

Two Case Reports

Siegel, R. S., & WEIDEN, I. (1968) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-196811000-00016 · Cited by 671 · see citing works

Compulsive buying: a report of 20 cases.

McElroy, S. L., Keck, P. E., Pope, H. G., Smith, J., & Strakowski, S. M. (1994) · PubMed · Cited by 646 · see citing works

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571 · see citing works

A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder

Eddy, K. T., Dutra, L., Bradley, R., & Westen, D. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.08.004 · Cited by 475 · see citing works

Treatment non-response in OCD: methodological issues and operational definitions

Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416 · see citing works

Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder

Saxena, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00082-2 · Cited by 379 · see citing works

Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine

ROSENBERG, D. R., MacMASTER, F. P., KESHAVAN, M. S., FITZGERALD, K. D., STEWART, C. M., & MOORE, G. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200009000-00008 · Cited by 377 · see citing works

Evidence-based pharmacotherapy of obsessive-compulsive disorder

Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336 · see citing works

Untitled work

(1996) · PubMed · Cited by 310 · see citing works

Paroxetine versus Clomipramine in the Treatment of Obsessive–Compulsive Disorder

Zohar, J., Judge, R., & Ocd Paroxetine Study Investigators (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.169.4.468 · Cited by 272 · see citing works

Long-Term Follow-Up and Predictors of Clinical Outcome in Obsessive-Compulsive Patients Treated With Serotonin Reuptake Inhibitors and Behavioral Therapy

Alonso, P., Menchón, J. M., Pifarré, J., Mataix‐Cols, D., Torres, L., Salgado, P., & Vallejo, J. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a06 · Cited by 254 · see citing works

A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors

Denys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248 · see citing works

High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder

Ninan, P. T., Koran, L. M., Kiev, A., Davidson, J. R. T., Rasmussen, S. A., Zajecka, J., Robinson, D. G., Crits-Christoph, P. F., Mandel, F. S., & Austin, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0103 · Cited by 246 · see citing works

Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine: A Placebo-Controlled Trial

Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220 · see citing works

Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?

Foa, E. B., Franklin, M. E., & Moser, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01552-4 · Cited by 219 · see citing works

Evidence-based pharmacotherapy of obsessive–compulsive disorder

Fineberg, N. A., & Gale, T. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004675 · Cited by 213 · see citing works

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression

Saxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., & Baxter, L. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.522 · Cited by 210 · see citing works

Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.

Kafka, M. P., & PRENTKY, R. A. (1992) · PubMed · Cited by 209 · see citing works

Neurobiology of the obsessive–compulsive spectrum disorders

Stein, D. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00271-1 · Cited by 204 · see citing works

Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder

Ackerman, D. L., & Greenland, S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00012 · Cited by 202 · see citing works

Differential Cerebral Metabolic Changes With Paroxetine Treatment of Obsessive-Compulsive Disorder vs Major Depression

Saxena, S., Brody, A. L., Ho, M. L., Alborzian, S., Maidment, K. M., Zohrabi, N., Ho, M. K., Huang, S., Wu, H.-M., & Baxter, L. R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.3.250 · Cited by 201 · see citing works

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder

McDougle, C. J., Epperson, C. N., Price, L. H., & Gelernter, J. E. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000391 · Cited by 200 · see citing works

Risperidone augmentation in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study

Hollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197 · see citing works

Clinical characteristics and treatment response in poor and good insight obsessive–compulsive disorder

Kishore, V. R., Samar, R., Reddy, Y. C. J., Chandrasekhar, C. R., & Thennarasu, K. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2003.12.005 · Cited by 192 · see citing works

Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.

Stein, D. J., Hollander, E., Anthony, D. T., Schneier, F. R., Fallon, B. A., Liebowitz, M. R., & Klein, D. F. (1992) · PubMed · Cited by 189 · see citing works

A Double-Blind Trial of Fluoxetine in Pathologic Skin Picking

Simeon, D., Stein, D. J., Gross, S., Islam, N., Schmeidler, J., & Hollander, E. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0802 · Cited by 186 · see citing works

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

Montgomery, S., Kasper, S. F., Stein, D. J., Hedegaard, K. B., & Lemming, O. M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200103000-00002 · Cited by 184 · see citing works

Sertraline Pharmacotherapy for Paraphilias and Paraphilia-Related Disorders: An Open Trial

Kafka, M. P. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409149003 · Cited by 179 · see citing works

Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study

Rauch, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00351-2 · Cited by 173 · see citing works

Placebo-Controlled Study of Fluvoxamine in the Treatment of Patients With Compulsive Buying

Ninan, P. T., McElroy, S. L., Kane, C. P., Knight, B. T., Casuto, L., Rose, S. E., Marsteller, F., & Nemeroff, C. B. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00012 · Cited by 172 · see citing works

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder

Montgomery, S. A. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90266-o · Cited by 172 · see citing works

Post-treatment effects of exposure therapy and clomipramine in obsessive–compulsive disorder

Simpson, H. B., Liebowitz, M. R., Foa, E. B., Kozak, M. J., Schmidt, A. B., Rowan, V., Petkova, E., Kjernisted, K., Huppert, J. D., Franklin, M. E., et al. (2004) · Depression and Anxiety · doi:10.1002/da.20003 · Cited by 161 · see citing works

Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine

Hollander, E., Allen, A., Steiner, M., Wheadon, D. E., Oakes, R., Burnham, D. B., & Paroxetine OCD Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0919 · Cited by 156 · see citing works

Obsessive compulsive spectrum disorders.

Rasmussen, S. A. (1994) · PubMed · Cited by 156 · see citing works

A Double-Blind Comparison of Fluvoxamine Versus Placebo in the Treatment of Compulsive Buying Disorder

Black, D. W., Gabel, J., Hansen, J., & Schlosser, S. (2000) · Annals of Clinical Psychiatry · doi:10.3109/10401230009147113 · Cited by 156 · see citing works

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder

Shapira, N. A., Ward, H. E., MANDOKI, M. W., Murphy, T. K., Yang, M. C. K., Blier, P., & Goodman, W. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.010 · Cited by 155 · see citing works

Fluvoxamine in the Treatment of Compulsive Buying

Black, D. W., Monahan, P. O., & Gabel, J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0404 · Cited by 152 · see citing works

A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder

Denys, D., van der Wee, N., van Megen, H. J. G. M., & Westenberg, H. G. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095342.32154.54 · Cited by 151 · see citing works

Quetiapine augmentation in patients with treatment resistant obsessive???compulsive disorder: a single-blind, placebo-controlled study

Atmaca, M., Kuloğlu, M. M., Tezcan, E., & Geçici, Ö. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00004 · Cited by 149 · see citing works

Defining Response in Clinical Trials for Obsessive-Compulsive Disorder

Tolin, D. F., Abramowitz, J. S., & Diefenbach, G. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1209 · Cited by 148 · see citing works

A Double-blind Comparison of Clomipramine and Desipramine Treatment of Severe Onychophagia (Nail Biting)

Leonard, H. L. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330045007 · Cited by 146 · see citing works

A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder

Denys, D. A. J. P., van Megen, H. J. G. M., van der Wee, N. J. A., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0106 · Cited by 144 · see citing works

WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults

Greist, J. H., Bandelow, B., Hollander, E., Marazziti, D., Montgomery, S., Nutt, D., Okasha, A., Swinson, R. P., & Zohar, J. (2003) · CNS Spectrums · doi:10.1017/s1092852900006908 · Cited by 143 · see citing works

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

Billett, E. A., Richter, M. A., King, N. A., Heils, A., Lesch, K., & Kennedy, J. L. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000257 · Cited by 143 · see citing works

Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive Disorder

Koran, L. M., Hackett, E., Rubin, A., Wolkow, R., & Robinson, D. G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.88 · Cited by 140 · see citing works

Obsessive-Compulsive Disorders: Practical Management

Jenike, M. A., Baer, L., & Minichiello, W. E. (1998) · Cited by 136 · see citing works

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study

Erzegovesi, S., Guglielmo, E., Siliprandi, F., & Bellodi, L. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.04.004 · Cited by 136 · see citing works

The Use of Aripiprazole in Obsessive-Compulsive Disorder

Connor, K. M., Payne, V., Gadde, K. M., Zhang, W., & Davidson, J. R. T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0107 · Cited by 135 · see citing works

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder

Greist, J. H., Jefferson, J. W., Kobak, K. A., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. W., Koran, L. M., Liebowtiz, M. R., Lydiard, B., et al. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199506000-00001 · Cited by 133 · see citing works

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Carey, P. D., Vythilingum, B., Seedat, S., Muller, J. E., van Ameringen, M., & Stein, D. J. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-5 · Cited by 133 · see citing works

Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder

Koran, L. M., Aboujaoude, E. N., Bullock, K. D., Franz, B., Gamel, N. N., & Elliott, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0312 · Cited by 132 · see citing works

Citalopram Treatment of Compulsive Shopping

Koran, L. M., Bullock, K. D., Hartston, H. J., Elliott, M. A., & D'Andrea, V. J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0808 · Cited by 131 · see citing works

Multicenter Double-blind Comparison of Sertraline and Desipramine for Concurrent Obsessive-Compulsive and Major Depressive Disorders

Hoehn‐Saric, R., Ninan, P. T., Black, D. W., Stahl, S. M., Greist, J. H., Lydiard, B., McElroy, S. L., Zajecka, J., Chapman, D. S., Clary, C. M., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.76 · Cited by 127 · see citing works

Topiramate augmentation in treatment-resistant obsessive–compulsive disorder: a retrospective, open-label case series

Ameringen, M. V., Mancini, C., Patterson, B. A., & Bennett, M. (2005) · Depression and Anxiety · doi:10.1002/da.20118 · Cited by 124 · see citing works

Predictive validity of the overvalued ideas scale: outcome in obsessive–compulsive and body dysmorphic disorders

Neziroglu, F., Stevens, K. P., McKay, D., & Yaryura-Tobias, J. A. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00053-x · Cited by 122 · see citing works

Refractory obsessive-compulsive disorder: state-of-the-art treatment.

Hollander, E., Bienstock, C. A., Koran, L. M., Pallanti, S., Marazziti, D., Rasmussen, S. A., Ravizza, L., Benkelfat, C., Saxena, S., Greenberg, B. D., et al. (2002) · PubMed · Cited by 119 · see citing works

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

Coric, V., Milanovic, S. M., Wasylink, S., Patel, P., Malison, R. T., & Krystal, J. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1396-z · Cited by 118 · see citing works

Response Acceleration With Mirtazapine Augmentation of Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid Depression

Pallanti, S., Quercioli, L., & Bruscoli, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1015 · Cited by 118 · see citing works

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

Dannon, P. N., Sasson, Y., Hirschmann, S., Iancu, I., Grunhaus, L. J., & Zohar, J. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00065-1 · Cited by 116 · see citing works

Fluoxetine in Pathologic Skin-Picking: Open-Label and Double-Blind Results

Bloch, M. R., Elliott, M., THOMPSON, H. B., & Koran, L. M. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.4.314 · Cited by 111 · see citing works

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

Fallon, B. A., Liebowitz, M. R., Campeas, R. B., Schneier, F. R., Marshall, R. D., Davies, S. O., Goetz, D. M., & Klein, D. F. (1998) · PubMed · doi:10.1001/archpsyc.55.10.918 · Cited by 111 · see citing works

Risperidone and Haloperidol Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder: A Crossover Study

Li, X., May, R. S., Tolbert, L. C., Jackson, W. T., Flournoy, J. M., & Baxter, L. R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0610 · Cited by 110 · see citing works

Neurotic excoriations: A review and some new perspectives

Gupta, M. A., Gupta, A. K., & Haberman, H. F. (1986) · Comprehensive Psychiatry · doi:10.1016/0010-440x(86)90014-3 · Cited by 110 · see citing works

A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder

Kaplan, A., & Hollander, E. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.8.1111 · Cited by 108 · see citing works

Long?term course and outcome of obsessive?compulsive patients after cognitive?behavioral therapy in combination with either fluvoxamine or placebo

Rufer, M., Hand, I., Alsleben, H., Braatz, A., Ortmann, J., Katenkamp, B., Fricke, S., & Peter, H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0544-8 · Cited by 107 · see citing works

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study

Fineberg, N. A., Sivakumaran, T., Roberts, A., & Gale, T. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200507000-00005 · Cited by 105 · see citing works

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder

Hollander, E., Koran, L. M., Goodman, W. K., Greist, J. H., Ninan, P. T., Yang, H., Li, D., & Barbato, L. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0604 · Cited by 103 · see citing works

Rapid benefit of intravenous pulse loading of clomipramine in obsessive- compulsive disorder

Koran, L. M., Sallee, F. R., & Pallanti, S. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.396 · Cited by 102 · see citing works

A randomized controlled trial of Japanese patients with obsessive–compulsive disorder—effectiveness of behavior therapy and fluvoxamine

Nakatani, E., Nakagawa, A., Nakao, T., Yoshizato, C., Nabeyama, M., Kudo, A., Isomura, K., Kato, N., Yoshioka, K., & Kawamoto, M. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000086317 · Cited by 102 · see citing works

Long-Term Treatment of Obsessive-Compulsive Disorder After an Acute Response: A Comparison of Fluoxetine Versus Placebo

Romano, S. J., Goodman, W. K., Tamura, R., & Gonzales, J. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00009 · Cited by 98 · see citing works

Cognitive Therapy and Exposure in Vivo Alone and in Combination With Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up

van Oppen, P., van Balkom, A. J. L. M., de Haan, E., & van Dyck, R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1111 · Cited by 97 · see citing works

An Open Clinical Trial of Fluvoxamine Treatment of Psychogenic Excoriation

Arnold, L. M., Mutasim, D. F., Dwight, M. M., Lamerson, C. L., Morris, E. M., & McElroy, S. L. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00005 · Cited by 97 · see citing works

A double-blind, placebo-controlled trial of clonazepam in obsessive–compulsive disorder

Hollander, E., Kaplan, A., & Stahl, S. M. (2003) · The World Journal of Biological Psychiatry · doi:10.3109/15622970309167908 · Cited by 97 · see citing works

A placebo-controlled cross-over trial of adjunctive EPA in OCD

Fux, M., Benjamin, J., & Nemets, B. (2004) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00077-3 · Cited by 95 · see citing works

Venlafaxine Versus Clomipramine in the Treatment of Obsessive-Compulsive Disorder

Albert, U., Aguglia, E., Maina, G., & Bogetto, F. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1108 · Cited by 93 · see citing works

Addition of cognitive‐behaviour therapy for obsessive‐compulsive disorder patients non‐responding to fluoxetine

Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Verbraak, M. J. P. M. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.01261.x · Cited by 93 · see citing works

An Open-Label Trial of St. John's Wort (Hypericum perforatum) in Obsessive-Compulsive Disorder

Taylor, L., & Kobak, K. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0806 · Cited by 92 · see citing works

Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

Koran, L. M., Gamel, N. N., Choung, H. W., Smith, E. H., & Aboujaoude, E. N. (2005) · PubMed · Cited by 91 · see citing works

Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study.

Coleman, E., Gratzer, T. G., Nesvacil, L. J., & Raymond, N. C. (2000) · PubMed · Cited by 83 · see citing works

Mirtazapine for Obsessive-Compulsive Disorder

Koran, L. M., Gamel, N. N., Choung, H. W., Smith, E. H., & Aboujaoude, E. N. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0415 · Cited by 83 · see citing works

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?

Sareen, J., Kirshner, A., Lander, M., Kjernisted, K. D., Eleff, M. K., & Reiss, J. P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.011 · Cited by 79 · see citing works

Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.

Pallanti, S., Quercioli, L., & Koran, L. M. (2002) · PubMed · Cited by 73 · see citing works

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response

Bella, D. D., Erzegovesi, S., Cavallini, M. C., & Bellodi, L. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500090 · Cited by 73 · see citing works

A Double-Blind Combination Study of Clonazepam with Sertraline in Obsessive-Compulsive Disorder

Crockett, B. A., Churchill, E., & Davidson, J. R. T. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490486972 · Cited by 72 · see citing works

Behavior therapy augments response of patients with obsessive–compulsive disorder responding to drug treatment

Tenneij, N. H., van Megen, H. J. G. M., Denys, D. A. J. P., & Westenberg, H. G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0913 · Cited by 71 · see citing works

Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

Stein, D. J., Montgomery, S., Kasper, S. F., & Tanghøj, P. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200111000-00007 · Cited by 70 · see citing works

Amisulpiride augmentation in treatment resistant obsessive–compulsive disorder: an open trial

Metin, Ö., Yazıcı, K., Tot, Ş., & Yazıcı, A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.512 · Cited by 68 · see citing works

A score for predicting response to pharmacotherapy in obsessive???compulsive disorder

Denys, D., Burger, H., van Megen, H., de Geus, F., & Westenberg, H. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200311000-00002 · Cited by 68 · see citing works

Fluvoxamine in obsessive‐compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine

Mundo, E., Rouillon, F., Figueira, M. L., & Stigler, M. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.317 · Cited by 66 · see citing works

Venlafaxine in Treatment-Resistant Obsessive-Compulsive Disorder

Hollander, E., Friedberg, J. P., Wasserman, S., Allen, A., Birnbaum, M., & Koran, L. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0508 · Cited by 66 · see citing works

Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder

Hewlett, W. A., Schmid, S. P., & Salomon, R. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0907 · Cited by 66 · see citing works

Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.

Selikowitz, M., Sunman, J., Pendergast, A., & Wright, S. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.1.112 · Cited by 63 · see citing works

Sertraline and Fluoxetine Treatment of Obsessive-Compulsive Disorder: Results of a Double-Blind, 6-Month Treatment Study

Bergeron, R., Ravindran, A. V., Chaput, Y., Goldner, E. M., Swinson, R. P., Ameringen, M. A. V., Austin, C., & Hadrava, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00007 · Cited by 62 · see citing works

Citalopram Treatment of Compulsive Shopping

Pallanti, S., Quercioli, L., & Koran, L. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0908 · Cited by 62 · see citing works

Antipsychotic augmentation for treatment resistant obsessive???compulsive disorder: what if antipsychotic is discontinued?

Maina, G., Albert, U., Ziero, S., & Bogetto, F. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000047784.24295.2b · Cited by 61 · see citing works

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine

Mundo, E., Guglielmo, E., & Bellodi, L. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199809000-00005 · Cited by 59 · see citing works

Lamotrigine Augmentation of Serotonin Re-Uptake Inhibitors in Obsessive–Compulsive Disorder

Kumar, T. C. R., & Khanna, S. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.0751c.x · Cited by 59 · see citing works

Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports

Warnock, J. K. (1992) · Archives of Dermatology · doi:10.1001/archderm.128.12.1623 · Cited by 57 · see citing works

Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?

Koran, L. M., Jw, C., Ra, D., Rush, A. J., & Thiemann, S. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.11.1450 · Cited by 56 · see citing works

Cerebral blood flow in obsessive–compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders

Hoehn‐Saric, R., Schlaepfer, T. E., Greenberg, B. D., McLeod, D. R., Pearlson, G. D., & Wong, S. H. (2001) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(01)00114-7 · Cited by 56 · see citing works

Inositol in the Treatment of Trichotillomania and Compulsive Skin Picking

Seedat, S., Stein, D. J., & Harvey, B. H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0112f · Cited by 56 · see citing works

Venlafaxine in Obsessive-compulsive Disorder

Yaryura-Tobias, J. A. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070103016 · Cited by 53 · see citing works

Long-Term Efficacy of Exposure and Ritual Prevention Therapy and Serotonergic Medications for Obsessive-Compulsive Disorder

Hembree, E. A., Riggs, D. S., Kozak, M. J., Franklin, M. E., & Foa, E. B. (2003) · CNS Spectrums · doi:10.1017/s1092852900018629 · Cited by 48 · see citing works

Emergence of Kleptomania During Treatment for Depression with Serotonin Selective Reuptake Inhibitors

Kindler, S., Dannon, P. N., Iancu, I., Sasson, Y., & Zohar, J. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199704000-00003 · Cited by 47 · see citing works

Quantitative Electroencephalography in OCD Patients Treated with Paroxetine

Hansen, E. S., Prichep, L. S., Bolwig, T. G., & John, E. R. (2003) · Clinical Electroencephalography · doi:10.1177/155005940303400205 · Cited by 47 · see citing works

Antipsychotic Treatment in Obsessive Compulsive Disorder: A Literature Review

Keuneman, R. J., Pokos, V., Weerasundera, R., & Castle, D. J. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01591.x · Cited by 46 · see citing works

Bupropion for Patients With Obsessive-Compulsive Disorder

Vulink, N. C. C., Denys, D. A. J. P., & Westenberg, H. G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0211 · Cited by 46 · see citing works

PHARMACOTHERAPY FOR OBSESSIVE-COMPULSIVE DISORDER

Hollander, E., Kaplan, A., Allen, A., & Cartwright, C. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70186-6 · Cited by 45 · see citing works

Nicotine treatment of obsessive–compulsive disorder

Lundberg, S., Carlsson, A., Norfeldt, P., & Carlsson, M. L. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.014 · Cited by 40 · see citing works

Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder.

(1997) · PubMed · Cited by 40 · see citing works

Platelet Serotonergic Markers as Endophenotypes for Obsessive-Compulsive Disorder

Delorme, R., Betancur, C., Callebert, J., Chabane, N., Laplanche, J., Mouren, M., Launay, J., & Leboyer, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300752 · Cited by 37 · see citing works

Paroxetine in the treatment of obsessive‐compulsive disorder: randomized, double‐blind, placebo‐controlled study in Japanese patients

Kamijima, K., Murasaki, M., Asai, M., Higuchi, T., Nakajima, T., Taga, C., & Matsunaga, H. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01278.x · Cited by 35 · see citing works

Effects of Donepezil on Compulsive Hypersexual Behavior in Parkinson Disease

Ivanco, L. S., & Bohnen, N. I. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000151861.59698.26 · Cited by 34 · see citing works

Citalopram in refractory obsessive-compulsive disorder: an open study

Marazziti, D., Dell’Osso, L., Gemignani, A., Ciapparelli, A., Presta, S., Nasso, E. D., Pfanner, C., & Cassano, G. B. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200107000-00005 · Cited by 33 · see citing works

Obsessive-Compulsive Spectrum Disorders: Effective Treatment with Paroxetine

Ravindran, A. V., Lapierre, Y. D., & Anisman, H. (1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904400808 · Cited by 32 · see citing works

Psychopharmacology of compulsive buying

Bullock, K. D., & Koran, L. (2003) · Drugs of today · doi:10.1358/dot.2003.39.9.799477 · Cited by 31 · see citing works

The adequacy of pharmacotherapy in outpatients with obsessive???compulsive disorder

Denys, D. A. J. P., van Megen, H. J. G. M., & Westenberg, H. G. M. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00003 · Cited by 31 · see citing works

Nicotine augmentation for refractory obsessive-compulsive disorder. A case report

Pasquini, M., Garavini, A., & Biondi, M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.011 · Cited by 31 · see citing works

Olanzapine Augmentation of Fluoxetine in the Treatment of Pathological Skin Picking

Christensen, R. C. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901121 · Cited by 28 · see citing works

Single Photon Emission Computed Tomography (SPECT) in Obsessive–Compulsive Disorder Before and After Treatment with Inositol

Carey, P. D., Warwick, J., Harvey, B. H., Stein, D. J., & Seedat, S. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000027423.34733.12 · Cited by 28 · see citing works

The Role of Venlafaxine in the Treatment of Obsessive—Compulsive Disorder

Phelps, N. J., & Cates, M. E. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e362 · Cited by 27 · see citing works

Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen

Bogetto, F., Albert, U., & Maina, G. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00012-3 · Cited by 26 · see citing works

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

Dell’Osso, B. M., Allen, A., & Hollander, E. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2727 · Cited by 26 · see citing works

Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive–compulsive disorder: possible mechanisms and implications for clinical care

Denys, D. A. J. P., van Megen, H. J. G. M., & Westenberg, H. G. M. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001718 · Cited by 25 · see citing works

Citalopram Concentrations and Response in Obsessive-Compulsive Disorder

Bareggi, S. R., Bianchi, L. K., Cavallaro, R., Gervasoni, M., Siliprandi, F., & Bellodi, L. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00004 · Cited by 21 · see citing works

Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects

Kasvikis, Y., & Marks, I. (1988) · Psychopharmacology · doi:10.1007/bf00212778 · Cited by 20 · see citing works

Predicting Treatment Response in Obsessive-Compulsive Disorder

Hurley, R. A., Saxena, S., Rauch, S. L., Hoehn‐Saric, R., & Taber, K. H. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.3.249 · Cited by 18 · see citing works

Failure of fluoxetine to modify the skin‐picking behaviour of Prader‐Willi syndrome

Schepis, C., Failla, P., Siragusa, M., Palazzo, R., & Romano, C. (1998) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.1998.tb01247.x · Cited by 16 · see citing works

Clomipramine Treatment of Sexual Preoccupation

Rubey, R. N., Brady, K. T., & Norris, G. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199304000-00015 · Cited by 16 · see citing works

Increased Maintenance of Obsessive-Compulsive Disorder Remission after Integrated Serotonergic Treatment and Cognitive Psychotherapy Compared with Medication Alone

Biondi, M., & Picardi, A. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000083172 · Cited by 16 · see citing works

Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder

Mathew, S. J., Coplan, J. D., Perko, K. A., Goetz, R. R., de la Neuz, M., Hollander, E., Liebowitz, M. R., & Fallon, B. A. (2001) · Depression and Anxiety · doi:10.1002/da.1067 · Cited by 14 · see citing works

Efficacy of olanzapine in the treatment of psychogenic excoriation

Blanch, J., Grimalt, F., Massana, G., & Navarro, V. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06151.x · Cited by 13 · see citing works

Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine

Ninan, P. T., & Beale, M. D. (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7063 · Cited by 11 · see citing works

Cessation of nail-biting and bupropion.

Wadden, P., & Pawliuk, G. (1999) · PubMed · Cited by 7 · see citing works

Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder

Denys, D., Mantione, M., Figee, M., van den Munckhof, P., Koerselman, F., Westenberg, H., Bosch, A., & Schuurman, R. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.122 · Cited by 763 · see citing works

Deep brain stimulation for obsessive-compulsive disorder: A meta-analysis of treatment outcome and predictors of response

Alonso, P., Cuadras, D., Gabriëls, L., Denys, D., Goodman, W., Greenberg, B. D., Jimenez-Ponce, F., Kuhn, J., Lenartz, D., Mallet, L., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133591 · Cited by 412 · see citing works

Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Phillips, K. A., Stein, D. J., Rauch, S. L., Hollander, E., Fallon, B. A., BARSKY, A. J., Fineberg, N. A., Mataix‐Cols, D., Ferrão, Y. A., Saxena, S., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20705 · Cited by 349 · see citing works

Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder

Luyten, L., Hendrickx, S., Raymaekers, S., Gabriëls, L., & Nuttin, B. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.124 · Cited by 264 · see citing works

Multiple pathways to functional impairment in obsessive-compulsive disorder

Markarian, Y., Larson, M. J., Aldea, M. A., Baldwin, S. A., Good, D., Berkeljon, A., Murphy, T. K., Storch, E. A., & McKay, D. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.09.005 · Cited by 252 · see citing works

Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets

de Koning, P. P., Figee, M., van den Munckhof, P., Schuurman, P. R., & Denys, D. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0200-8 · Cited by 202 · see citing works

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder

Storch, E. A., Merlo, L. J., Bengtson, M., Murphy, T. K., Lewis, M. H., Yang, M. C., Jacob, M. L., Larson, M., Hirsh, A., Fernandez, M., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32819f8480 · Cited by 200 · see citing works

Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder

Denys, D. A. J. P., de Vries, F., Cath, D. C., Figee, M., Vulink, N. C. C., Veltman, D. J., van der Doef, T. F., Boellaard, R., Westenberg, H. G. M., van Balkom, A. J. L. M., et al. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.012 · Cited by 167 · see citing works

Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

Fineberg, N. A., Hollander, E., Pallanti, S., Walitza, S., Grünblatt, E., Dell’Osso, B. M., Albert, U., Geller, D. A., Brakoulias, V., Janardhan Reddy, Y. C., et al. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000314 · Cited by 161 · see citing works

Efficacy of Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Refractory Obsessive-Compulsive Disorder: A Clinical Cohort of 70 Patients

Denys, D. A. J. P., Graat, I., Mocking, R. J. T., de Koning, P. P., Vulink, N. C. C., Figee, M., Ooms, P., Mantione, M. H. M., van den Munckhof, P., & Schuurman, R. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19060656 · Cited by 159 · see citing works

Cortico–Basal Ganglia Circuit Function in Psychiatric Disease

Gunaydin, L. A., & Kreitzer, A. C. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105355 · Cited by 147 · see citing works

Deep Brain Stimulation in the Treatment of Obsessive-Compulsive Disorder

Blomstedt, P. C., Sjöberg, R. L., Hansson, M., Bodlund, O., & Hariz, M. I. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.10.006 · Cited by 137 · see citing works

Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder

Mantione, M., Nieman, D. H., Figee, M., & Denys, D. (2014) · Psychological Medicine · doi:10.1017/s0033291714000956 · Cited by 129 · see citing works

Compulsive features in behavioural addictions: the case of pathological gambling

el‐Guebaly, N., Mudry, T., Zohar, J., Tavares, H., & Potenza, M. N. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03546.x · Cited by 130 · see citing works

Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder

Ting, J. T., & Feng, G. (2008) · Current Chemical Genomics · doi:10.2174/1875397300802010062 · Cited by 121 · see citing works

The relationship between impulse-control disorders and obsessive–compulsive disorder: A current understanding and future research directions

Potenza, M. N., Koran, L. M., & Pallanti, S. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.036 · Cited by 121 · see citing works

Connectomic deep brain stimulation for obsessive-compulsive disorder

Baldermann, J. C., Schüller, T., Kohl, S., Voon, V., Li, N., Hollunder, B., Figee, M., Haber, S. N., Sheth, S. A., Mosley, P. E., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.07.010 · Cited by 118 · see citing works

Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial

Mansur, C. G., Myczkowski, M. L., Cabral, S. D. B., Sartorelli, M. C., Bellini, B. B., Dias, Á. M., Bernik, M., & Marcolin, M. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000575 · Cited by 111 · see citing works

Deep brain stimulation for treatment-refractory obsessive compulsive disorder: a systematic review

Kohl, S., Schönherr, D. M., Luigjes, J., Denys, D. A. J. P., Mueller, U. J., Lenartz, D., Visser-Vandewalle, V. E. R. M., & Kuhn, J. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0214-y · Cited by 110 · see citing works

Stereotypic behaviour in the deer mouse: Pharmacological validation and relevance for obsessive compulsive disorder

Schaun Korff, A., Stein, D. J., & Harvey, B. H. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.032 · Cited by 105 · see citing works

Deep brain stimulation for obsessive-compulsive disorders: long-term analysis of quality of life

Ooms, P., Mantione, M. H. M., Figee, M., Schuurman, P. R., van den Munckhof, P., & Denys, D. A. J. P. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302550 · Cited by 103 · see citing works

Deep brain stimulation for psychiatric disorders: where we are now

Cleary, D. R., Ozpinar, A., Raslan, A. M. T., & Ko, A. L. (2015) · Neurosurgical FOCUS · doi:10.3171/2015.3.focus1546 · Cited by 99 · see citing works

A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder

Menchón, J. M., Real, E., Alonso, P., Aparicio, M. A., Segalàs, C., Plans, G., Luyten, L., Brunfaut, E., Matthijs, L., Raymaekers, S., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0562-6 · Cited by 94 · see citing works

8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder

Maina, G., Pessina, E., Albert, U., & Bogetto, F. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.001 · Cited by 92 · see citing works

Deep-brain stimulation for basal ganglia disorders

Wichmann, T., & DeLong, M. R. (2011) · Basal Ganglia · doi:10.1016/j.baga.2011.05.001 · Cited by 89 · see citing works

Deep Brain Stimulation for Obsessive Compulsive Disorder: Evolution of Surgical Stimulation Target Parallels Changing Model of Dysfunctional Brain Circuits

Karas, P. J., Lee, S., Shahed, J. J., Goodman, W. K., Viswanathan, A., & Sheth, S. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00998 · Cited by 89 · see citing works

Animal models of obsessive–compulsive disorder: utility and limitations

Alonso, P., López‐Solà, C., Real, E., Segalàs, C., & Menchón, J. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62785 · Cited by 84 · see citing works

A Unified Functional Network Target for Deep Brain Stimulation in Obsessive-Compulsive Disorder

Li, N., Hollunder, B., Baldermann, J. C., Kibleur, A., Treu, S., Akram, H., Al‐Fatly, B., Strange, B. A., Barcia, J. A., Zrinzo, L. U., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.006 · Cited by 81 · see citing works

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD

Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Hollander, E., Kasper, S., Möller, H.-J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086296 · Cited by 84 · see citing works

Long-term Outcome of Deep Brain Stimulation of the Ventral Part of the Anterior Limb of the Internal Capsule in a Cohort of 50 Patients With Treatment-Refractory Obsessive-Compulsive Disorder

Graat, I., Mocking, R. J. T., Figee, M., Vulink, N. C. C., de Koning, P. P., Ooms, P., Mantione, M. H. M., van den Munckhof, P., Schuurman, R., & Denys, D. A. J. P. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.08.018 · Cited by 73 · see citing works

Update on Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Different Targets

Blom, R. M., Figee, M., Vulink, N. C. C., & Denys, D. A. J. P. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0205-3 · Cited by 72 · see citing works

Deep Brain Stimulation of the Nucleus Accumbens and Bed Nucleus of Stria Terminalis for Obsessive-Compulsive Disorder: A Case Series

Islam, L., Franzini, A., Messina, G., Scarone, S., & Gambini, O. (2014) · World Neurosurgery · doi:10.1016/j.wneu.2014.12.024 · Cited by 69 · see citing works

A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals.

Andersen, S., Greene-Colozzi, E. A., & Sonntag, K. C. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.011 · Cited by 65 · see citing works

Active Stimulation Site of Nucleus Accumbens Deep Brain Stimulation in Obsessive–Compulsive Disorder Is Localized in the Ventral Internal Capsule

van den Munckhof, P., Bosch, D. A., Mantione, M. H. M., Figee, M., Denys, D. A. J. P., & Schuurman, P. R. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1482-7_9 · Cited by 65 · see citing works

Surgery for Psychiatric Disorders

Luigjes, J., de Kwaasteniet, B. P., de Koning, P. P., Oudijn, M. S., van den Munckhof, P., Schuurman, P. R., & Denys, D. A. J. P. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.03.009 · Cited by 67 · see citing works

The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor‐refractory obsessive‐compulsive disorder: a single‐blind, randomised study

Selvı, Y., Atlı, A., Aydın, A., Beşiroğlu, L., Özdemir, P. G., & Özdemir, O. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1169 · Cited by 64 · see citing works

The anteromedial GPi as a new target for deep brain stimulation in obsessive compulsive disorder

Nair, G., Evans, A. H., Bear, R. E., Velakoulis, D., & Bittar, R. G. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.10.003 · Cited by 64 · see citing works

Clinical outcome and mechanisms of deep brain stimulation for obsessive-compulsive disorder

van Westen, M., Rietveld, E., Figee, M., & Denys, D. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0036-3 · Cited by 60 · see citing works

Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients

Swierkosz-Lenart, K., Santos, J. F. A. D., Elowe, J., Clair, A.-H., Bally, J. F., Riquier, F., Bloch, J., Draganski, B., Clerc, M.-T., Moyano, B. P., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1065812 · Cited by 67 · see citing works

Deep Brain Stimulation for Obsessive-Compulsive Disorder: Optimal Stimulation Sites

Meyer, G. M., Hollunder, B., Li, N., Butenko, K., Dembek, T. A., Hart, L., Nombela, C., Mosley, P. E., Akram, H., Acevedo, N., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.12.010 · Cited by 58 · see citing works

Long-term electrical stimulation of bed nucleus of stria terminalis for obsessive-compulsive disorder

Raymaekers, S., Vansteelandt, K., Luyten, L., Bervoets, C., Demyttenaere, K., Gabriëls, L. A., & Nuttin, B. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.124 · Cited by 57 · see citing works

Anatomic Review of the Ventral Capsule/Ventral Striatum and the Nucleus Accumbens to Guide Target Selection for Deep Brain Stimulation for Obsessive-Compulsive Disorder

Park, Y. S., Sammartino, F., Young, N. A., Corrigan, J. D., Krishna, V., & Rezai, A. R. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.01.254 · Cited by 58 · see citing works

Deep brain stimulation versus ablative surgery for treatment‐refractory obsessive‐compulsive disorder: A meta‐analysis

Hageman, S. B., van Rooijen, G., Bergfeld, I. O., Schirmbeck, F., de Koning, P., Schuurman, P. R., & Denys, D. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13276 · Cited by 56 · see citing works

Behavioral flexibility in a mouse model for obsessive‐compulsive disorder: Impaired Pavlovian reversal learning in SAPAP3 mutants

van den Boom, B. J. G., Mooij, A. H., Misevičiūtė, I., Denys, D., & Willuhn, I. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12557 · Cited by 55 · see citing works

Therapeutic Neurostimulation in Obsessive-Compulsive and Related Disorders: A Systematic Review

Acevedo, N., Bosanac, P., Pikoos, T. D., Rossell, S. L., & Castle, D. J. (2021) · Brain Sciences · doi:10.3390/brainsci11070948 · Cited by 55 · see citing works

Differential Effects of Deep Brain Stimulation of the Internal Capsule and the Striatum on Excessive Grooming in Sapap3 Mutant Mice

Pinhal, C. M., van den Boom, B. J. G., Santana-Kragelund, F., Fellinger, L., Bech, P., Hamelink, R., Feng, G., Willuhn, I., Feenstra, M. G. P., & Denys, D. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.011 · Cited by 54 · see citing works

Role of nitric oxide in obsessive–compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice

Umathe, S. N., Bhutada, P., Jain, N. S., Mundhada, Y. R., Borkar, S. S., & Dhumal, B. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.07.001 · Cited by 54 · see citing works

Neuromodulation in Obsessive-Compulsive Disorder

Bais, M., Figee, M., & Denys, D. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.06.003 · Cited by 53 · see citing works

Neurosurgical targets for compulsivity: What can we learn from acquired brain lesions?

Figee, M., Wielaard, I., Mazaheri, A., & Denys, D. A. J. P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.005 · Cited by 53 · see citing works

Recent Advances in the Understanding and Treatment of Anxiety Disorders

Shearer, S. L. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.05.002 · Cited by 53 · see citing works

Deep brain stimulation of the subthalamic nucleus in obsessive–compulsives disorders: long-term follow-up of an open, prospective, observational cohort

Chabardès, S., Krack, P., Piallat, B., Bougerol, T., Seigneuret, É., Yelnik, J., Fernández-Vidal, S., Olivier David, A., Mallet, L., Benabid, A., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323421 · Cited by 52 · see citing works

LHRH antagonist attenuates the effect of fluoxetine on marble-burying behavior in mice

Gaikwad, U., Bhutada, P., Manish, W., & Umathe, S. N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.016 · Cited by 52 · see citing works

Deep brain stimulation modulates directional limbic connectivity in obsessive-compulsive disorder

Fridgeirsson, E. A., Figee, M., Luigjes, J., van den Munckhof, P., Schuurman, P. R., van Wingen, G., & Denys, D. (2020) · Brain · doi:10.1093/brain/awaa100 · Cited by 51 · see citing works

Deep brain stimulation in mental health: Review of evidence for clinical efficacy

Fitzgerald, P. B., & Segrave, R. A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415598011 · Cited by 47 · see citing works

Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse

Güldenpfennig, M., Wolmarans, D. W., du Preez, J. L., Stein, D. J., & Harvey, B. H. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.03.008 · Cited by 45 · see citing works

Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder

Ooms, P., Blankers, M., Figee, M., Bergfeld, I. O., van den Munckhof, P., Schuurman, P. R., & Denys, D. A. J. P. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.04.120 · Cited by 43 · see citing works

Invasive and Non-invasive Neurostimulation for OCD

Bergfeld, I. O., Dijkstra, E., Graat, I., de Koning, P. P., van den Boom, B. J. G., Arbab, T., Vulink, N. C. C., Denys, D. A. J. P., Willuhn, I., & Mocking, R. J. T. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_206 · Cited by 43 · see citing works

An update on the pharmacological treatment of obsessive-compulsive disorder

Fontenelle, L. F., Nascimento, A. L., Mendlowicz, M. V., Shavitt, R. G., & Versiani, M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.5.563 · Cited by 42 · see citing works

Quetiapine Addition in Obsessive-Compulsive Disorder: Is Treatment Outcome Affected by Type and Dose of Serotonin Reuptake Inhibitors?

Denys, D. A. J. P., Fineberg, N. A., Carey, P. D., & Stein, D. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.014 · Cited by 41 · see citing works

Neurosteroids modulate compulsive and persistent behavior in rodents: Implications for obsessive–compulsive disorder

Umathe, S. N., Vaghasiya, J. M., Jain, N. S., & Dixit, P. V. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.013 · Cited by 40 · see citing works

The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap

Szechtman, H., Harvey, B. H., Woody, E. Z., & Hoffman, K. L. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017772 · Cited by 40 · see citing works

Glutamate, obsessive–compulsive disorder, schizophrenia, and the stability of cortical attractor neuronal networks

Rolls, E. T. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.017 · Cited by 39 · see citing works

Deep Brain Stimulation for Obsessive–Compulsive Disorder: A Long Term Naturalistic Follow Up Study in a Single Institution

Holland, M. T., Trapp, N. T., McCormick, L. M., Jareczek, F. J., Zanaty, M., Close, L. N., Beeghly, J. H. L., & Greenlee, J. D. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00055 · Cited by 38 · see citing works

Off-label prescription of quetiapine in psychiatric disorders

ROWE, D. L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.841 · Cited by 39 · see citing works

Long-Term Deep Brain Stimulation in Treatment-Resistant Obsessive-Compulsive Disorder: Outcome and Quality of Life at Four to Eight Years Follow-Up

Winter, L., Saryyeva, A., Schwabe, K., Heissler, H. E., Runge, J., Alam, M., Heitland, I., Kahl, K. G., & Krauss, J. K. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13232 · Cited by 38 · see citing works

Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case series

Farrand, S., Evans, A. H., Mangelsdorf, S., Loi, S. M., Mocellin, R., Borham, A., Bevilacqua, J., Blair‐West, S., Walterfang, M., Bittar, R. G., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417731819 · Cited by 36 · see citing works

Untitled work

(2010) · Cited by 35 · see citing works

Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats

de Haas, R., Nijdam, A., Westra, T. A., Kas, M. J., & Westenberg, H. G. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110389093 · Cited by 35 · see citing works

Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice

Vinchurney, M. D., Thakre, P. P., Pannase, A. S., Aglawe, M. M., Taksande, B. G., & Kotagale, N. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.045 · Cited by 34 · see citing works

Genetics of obsessive–compulsive disorder: a research update

Grados, M. A., & Wilcox, H. C. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.8.967 · Cited by 33 · see citing works

Effects of deep brain stimulation on prepulse inhibition in obsessive-compulsive disorder

Kohl, S., Gruendler, T. O. J., Huys, D., Sildatke, E., Dembek, T. A., Hellmich, M., Vorderwulbecke, M., Timmermann, L., Ahmari, S. E., Klosterkoetter, J., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.171 · Cited by 30 · see citing works

The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder

Moon, W., Kim, S. N., Park, S. M., Paek, S. H., & Kwon, J. S. (2017) · Medicine · doi:10.1097/md.0000000000007397 · Cited by 30 · see citing works

Pressing ethical issues in considering pediatric deep brain stimulation for obsessive-compulsive disorder

Muñoz, K. A., Kostick, K. M., Torgerson, L. N., Zuk, P. D., Kalwani, L., Sanchez, C. E., Blumenthal‐Barby, J., Storch, E. A., & Lázaro‐Muñoz, G. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.10.388 · Cited by 29 · see citing works

Deep brain stimulation and ablation for obsessive compulsive disorder: evolution of contemporary indications, targets and techniques

Tierney, T. S., Abd‐El‐Barr, M. M., Stanford, A. D., Foote, K. D., & Okun, M. S. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.852086 · Cited by 29 · see citing works

Ablative neurosurgery and deep brain stimulation for obsessive-compulsive disorder

Arumugham, S. S., Balachander, S., & Srinivas, D. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_523_18 · Cited by 30 · see citing works

The Effects of Transcranial Direct Current Stimulation in Obsessive–Compulsive Disorder Symptoms: A Meta-Analysis and Integrated Electric Fields Modeling Analysis

Pinto, B. S., Cavendish, B. A., da Silva, P. H. R., Suen, P. J. C., Marinho, K. A. P., Valiengo, L. D. C. L., Vanderhasselt, M., Brunoni, A. R., & Razza, L. B. (2022) · Biomedicines · doi:10.3390/biomedicines11010080 · Cited by 27 · see citing works

Increased expression of 5‐HT6receptors in dorsolateral striatum decreases habitual lever pressing, but does not affect learning acquisition of simple operant tasks in rats

Eskenazi, D., & Neumaier, J. F. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07756.x · Cited by 25 · see citing works

Progress and challenges in deep brain stimulation for obsessive-compulsive disorder

Kohl, S., & Baldermann, J. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.011 · Cited by 25 · see citing works

Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms

Collins, H. M. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae057 · Cited by 24 · see citing works

Deep brain stimulation in the management of paediatric neuropsychiatric conditions: Current evidence and future directions

Ashkan, K., Mirza, A. B., Tambirajoo, K., & Furlanetti, L. L. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.09.004 · Cited by 24 · see citing works

Surgical Approaches in Psychiatry: A Survey of the World Literature on Psychosurgery

Neumaier, F., Paterno, M., Alpdogan, S., Tevoufouet, E. E., Schneider, T., Hescheler, J., & Albanna, W. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.10.008 · Cited by 24 · see citing works

New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder

Figee, M., & Denys, D. A. J. P. (2009) · CNS Spectrums · doi:10.1017/s1092852900027255 · Cited by 24 · see citing works

State of the Art: Novel Applications for Deep Brain Stimulation

Roy, H., Green, A. L., & Aziz, T. Z. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12604 · Cited by 23 · see citing works

Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD)

Tucci, M. C., Dvorkin‐Gheva, A., Sharma, R., Taji, L., Cheon, P., Peel, J. K., Kirk, A., & Szechtman, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3505-6 · Cited by 23 · see citing works

Deep brain stimulation for obsessive-compulsive disorder: Knowledge and concerns among psychiatrists, psychotherapists and patients

Naesstr, M., Blomstedt, P. C., Hariz, M. I., & Bodlund, O. (2017) · Surgical Neurology International · doi:10.4103/sni.sni_19_17 · Cited by 23 · see citing works

A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder

Matsunaga, H., Hayashida, K., Maebayashi, K., 三戸, 宏., & Kiriike, N. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.605958 · Cited by 23 · see citing works

Effectiveness and safety of deep brain stimulation for patients with refractory obsessive compulsive disorder and comorbid autism spectrum disorder; A case series

Graat, I., Balke, S., Prinssen, J., de Koning, P. P., Vulink, N. C. C., Mocking, R. J. T., van Rooijen, G., van den Munckhof, P., Schuurman, R., & Denys, D. A. J. P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.089 · Cited by 22 · see citing works

Deep brain stimulation for psychiatric disorders and behavioral/cognitive-related indications: Review of the literature and implications for treatment

Mahoney, J. J., Koch-Gallup, N., Scarisbrick, D. M., Berry, J. H., & Rezai, A. R. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120253 · Cited by 21 · see citing works

The potent inhibitory effect of tipepidine on marble-burying behavior in mice

Honda, S., Kawaura, K., Soeda, F., Shirasaki, T., & Takahama, K. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.010 · Cited by 20 · see citing works

Altered functional connectivity of the subthalamus and the bed nucleus of the stria terminalis in obsessive–compulsive disorder

Cano, M., Alonso, P., Martínez‐Zalacaín, I., Subirà, M., Real, E., Segalàs, C., Pujol, J., Cardoner, N., Menchón, J. M., & Soriano‐Mas, C. (2017) · Psychological Medicine · doi:10.1017/s0033291717002288 · Cited by 20 · see citing works

The role of early-life family composition and parental socio-economic status as risk factors for obsessive-compulsive disorder in a Danish national cohort

Yılmaz, Z., Larsen, J. T., Nissen, J. B., Crowley, J. J., Mattheisen, M., Bulik, C. M., & Petersen, L. V. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.004 · Cited by 19 · see citing works

Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysis of randomised, placebo-controlled trials

Cohen, S. E., Zantvoord, J. B., Storosum, B. W. C., Mattila, T. K., Daams, J. G., Wezenberg, B. N., de Boer, A., & Denys, D. A. J. P. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2023-300951 · Cited by 19 · see citing works

A Comprehensive Review of the Use of Deep Brain Stimulation ( DBS ) in Treatment of Psychiatric and Headache Disorders

Altinay, M. I., Estemalik, E., & Malone, D. A. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12517 · Cited by 18 · see citing works

Neuromodulation for obsessive-compulsive disorder

Aronson, J. P., Katnani, H. A., & Eskandar, E. N. (2014) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2013.08.003 · Cited by 18 · see citing works

D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis

Yu, X., Xia, J., Du, Y., Han, J., & Liu, G. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s68994 · Cited by 18 · see citing works

Expanding indications for deep brain stimulation

Doshi, P. (2018) · Neurology India · doi:10.4103/0028-3886.226450 · Cited by 17 · see citing works

Is deep brain stimulation effective and safe for patients with obsessive compulsive disorder and comorbid bipolar disorder?

Graat, I., van Rooijen, G., Mocking, R. J. T., Vulink, N. C. C., de Koning, P. P., Schuurman, R., & Denys, D. A. J. P. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.152 · Cited by 16 · see citing works

Deep brain stimulation and sensorimotor gating in tourette syndrome and obsessive-compulsive disorder

Schleyken, S., Baldermann, J. C., Huys, D., Franklin, J. G., Visser-Vandewalle, V. E. R. M., Kuhn, J. H., & Kohl, S. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.016 · Cited by 17 · see citing works

Extrapyramidal Side Effects in a Blue and Gold Macaw (Ara ararauna) Treated With Haloperidol and Clomipramine

Starkey, S. R., Morrisey, J. K., Hickam, H. D., Albright, J. D., & Lynch, M. J. (2008) · Journal of Avian Medicine and Surgery · doi:10.1647/2007-037.1 · Cited by 17 · see citing works

Efficacy and acceptability of brain stimulation for anxiety disorders, OCD, and PTSD: A systematic review and network meta-analysis of randomized controlled trials

Yang, X., Ma, L., Fan, C. G., Wang, H., Zhang, M., Du, H., Zhou, T., & Li, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.071 · Cited by 16 · see citing works

Pharmacotherapy for obsessive‐compulsive disorder

Dougherty, D. D., Rauch, S. L., & Jenike, M. A. (2004) · Journal of Clinical Psychology · doi:10.1002/jclp.20083 · Cited by 83 · see citing works

Pharmacological treatment for obsessive–compulsive disorder

Fineberg, N. A., & Craig, K. J. (2007) · Psychiatry · doi:10.1016/j.mppsy.2007.04.001 · Cited by 26 · see citing works

Pharmacotherapy of obsessive-compulsive disorder

Pigott, T. A., & Seay, S. (1997) · International Review of Psychiatry · doi:10.1080/09540269775655 · Cited by 19 · see citing works

Pharmacological Treatment of Obsessive-Compulsive Disorder

Simpson, H. B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_12 · Cited by 59 · see citing works

A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder

Kaplan, A., & Hollander, E. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.8.1111 · Cited by 108 · see citing works